Executive Board

Dr. Danny Chu is currently a Clinical Instructor at Albert Einstein School of Medicine and an attending physician at Beth Israel Medical Center. Dr. Chu received his Bachelor of Arts at Columbia University in New York City and his Medical Doctorate at George Washington University Medical School in Washington, D.C. He completed his medical training in New York City with an internal medicine residency at Beth Israel Medical Center, a gastroenterology fellowship at St. Luke's Roosevelt Hospital and a hepatology fellowship at Mt. Sinai Medical Center.

Upon completion of his training, he opened a gastroenterology practice in the Chinatown section of New York City. With the availability of an oral anti-viral, one of his main interests has been chronic hepatitis B. As a community physician, he has taken an active role in advocating HBV screening and vaccination by working with various groups such as the Charles B. Wang Community Health Center. He is also active in educating healthcare providers with lectures on HBV at grand rounds, medical society meetings and round table discussions.

Dr. Son Do is a first generation Vietnamese American, who immigrated as a refugee to the US, after the fall of the Republic of Vietnam in 1975. He graduated from the University of Kansas. He completed his residency at the University of Kansas, chief residency at Dwight Eisenhower VA Hospital, and gastroenterology fellowship and University of Arizona in Tucson.

Dr. Do is among the founding Board members of Digestive Health Associates of Texas (DHAT), one of the largest single specialty gastroenterology group in the country, with over 75 members. He is also currently a clinical instructor at University of Texas Southwestern. He has been in practice for 19 years.

Dr. Do is actively involved in promoting cancer screening and hepatitis B screening/treatment for Asian Americans. He has served as the Chairman of the National CDC Task Force for Hepatitis B in Asian Americans. He also is participating in clinical researchs for both hepatitis B and C, including the 7-year NIH-directed multicenter hepatitis B Research Network.

Dr. Do is the immediate past Chairman of the Board of Directors for the Vietnamese American Medical Association, a national organization with 13 regional chapters. He is also a board member of the National Council of Asian Pacific Islander Physicians. He is a member of the Colorectal Committee at Texas Health Plano hospital and a member or Electronic Health Record Committee for DHAT.

Dr. W. Ray Kim is currently an Association Professor of Medicine at Mayo clinic College of Medicine and a consultant in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN. Dr. Kim's primary clinical interest is viral hepatitis including hepatitis B. He leads hepatitis B programs at Mayo Clinic Rochester. In addition, he has active research programs in viral hepatitis and liver transplantation. Extramurally, he has served on committees at the National Institutes of Health, the Center for Disease Control and Prevention and American Association for the Study of Liver Diseases. Currently, he is an Associate Editor of Hepatology. Dr. Kim received his medical degree at Seoul National University in Seoul, Korea. He underwent training in Gastroenterology at Mayo Clinic Rochester. Additionally, he was an advanced fellow in Hepatology and Liver Transplantation before he joined the staff at Mayo Clinic Rochester.

Anna S.F. Lok, MD, is a professor of internal medicine and the director of clinical hepatology at the University of Michigan Medical Center. Dr. Lok graduated from the medical school at the University of Hong Kong and received her training in hepatology under the late Professor Dame Sheila Sherlock at the Royal Free Hospital in London.

Dr. Lok is a world renowned hepatologist and one of the premier leaders in hepatitis B research. She has made seminal contributions to our understanding of the natural history and treatment of hepatitis B. She has published more than 250 papers on viral hepatitis and liver diseases. She is a co-author of the American Association for the Study of Liver Diseases Practice Guidelines on Management of Hepatitis B.

During her distinguished career, she has received numerous awards for research and teaching including most recently the Hepatitis B Foundation 2008 Distinguished Scientist Award, and the American Gastroenterological Association Foundation 2008 Outstanding Women in Science.

Dr. Lok served on the governing board of the American Association for the Study of Liver Diseases from 2001-2003, and as an Associate Editor for HEPATOLOGY from 2001-2006. She is currently Co-Editor of the Journal of Viral Hepatitis.

Albert D. Min, MD, is the Director of Hepatology at Beth Israel Medical Center and Professor of Clinical Medicine at the Albert Einstein College of Medicine in New York. Prior to joining Beth Israel, he was an Assistant Professor of Medicine and the Director of Liver Clinic at the Mount Sinai School of Medicine.

Dr. Min earned his AB in Chemistry, cum laude at Cornell University in Ithaca, New York, and his MD at the University of Rochester School of Medicine and Dentistry in Rochester, New York. After graduating, he completed his internship and residency in internal medicine at the State University of New York at Stony Brook. His fellowship in Gastroenterology/Hepatology was completed at the Albert Einstein College of Medicine.

Dr. Min's research interests are primarily devoted to the study and treatment of chronic liver disease, particularly in chronic hepatitis B and C, and hepatocellular carcinoma. His articles concerning these and related topics are published in Hepatology, Gastroenterology, Journal of Clinical Investigation, Liver Transplantation, Journal of Viral Hepatitis, Journal of Clinical gastroenterology, and American Journal of Gastroenterology, among others. He also has conducted numerous invited lectures in his field. He is a member of the American Association for the Study of Liver Diseases and the American Gastroenterological Association. He has been also selected in the Best doctors in America, 2005-2010, and was a past president of the New York Gastroenterological Association for the 2006-2007 academic year.

Jocelyn Woog is an attorney by training. She has served as an executive director, administrator and communications specialist working with the Department of Public Health of the Commonwealth of Massachusetts and with non-profit organizations in Massachusetts and Minnesota. Ms. Woog received her B.F.A. in Communications from New York University and her J.D. Cum Laude from Suffolk University Law School in Boston. Ms. Woog has experience with grant writing and administration, budget development, and strategic planning, and has enjoyed working with stakeholders including corporate sponsors, governmental agencies, and patient advocacy groups to achieve organizational goals.